Early postoperative care of liver transplantation for infants with biliary atresia during pediatric intensive care unit stay.
METHODS
The aim of this study was to present our institutional experience with the pediatric intensive care unit (PICU) stays of liver recipients to understand prevention of complications.


METHODS
This retrospective review included 22 infants who weighed 8.8 kg or less and underwent 23 transplantations. No grafts were from executed prisoners. We summarized the diagnosis, evaluation, medicine usage, and therapeutic intervention associated with subjects experiencing complications of rejection episodes, surgery, or infection during their ICU stay.


RESULTS
There was one perioperative death from primary graft nonfunction. The most common postoperative complications were infections, gastrointestinal bleeding, and vascular complications. Rejection episodes occurred among 25% of patients. The most common isolated pathogenic bacteria was Staphylococcus epidermidis. Median initial ICU stay was 10 days. Mean requirement for artificial ventilation was 37.6 hour. Mean times of use of dobutamine, prostaglandin E1, and dopamine was 3.3, 7.5, and 8.8 days, respectively. Parenteral nutrition was started at a mean of 12 hours and oral food intake at a mean of 72 hours.


CONCLUSIONS
Although challenging, orthotopic liver transplantation (OLT) in small infants can be successfully performed with meticulous surgical technique and keen postoperative surveillance.
Guo
C-B
CB
Department of Hepatobiliary Surgery, Children's Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Li
Y-C
YC
Zhang
M-M
MM
Yan
L-N
LN
Pu
C-L
CL
Kang
Q
Q
Jin
X-Q
XQ
D000527:Alprostadil / Q000627:therapeutic use; D001424:Bacterial Infections / Q000145:classification; D001656:Biliary Atresia / Q000601:surgery*; D001835:Body Weight; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D015278:Intensive Care Units, Pediatric / Q000592:standards* / Q000706:statistics & numerical data; D007902:Length of Stay; D016031:Liver Transplantation / Q000276:immunology / Q000379:methods* / Q000592:standards; D009853:Omeprazole / Q000627:therapeutic use; D009929:Organ Size; D011182:Postoperative Care / Q000592:standards*; D011183:Postoperative Complications / Q000382:microbiology
D002316:Cardiotonic Agents; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D004280:Dobutamine; D000527:Alprostadil; D009853:Omeprazole; D004298:Dopamine